Abstract
Available data suggest that patients who have a limited number of pulmonary metastases may benefit from complete surgical resection if they have favorable prognostic features such as a long TDT and a long DFI. If a patient is not a surgical candidate because of radiographic evidence of extrapulmonary disease, a short TDT, or a short DFI, then concurrent or sequential biochemotherapy offers the best chance for a complete response and remission.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Humans
-
Immunotherapy
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary*
-
Lung Neoplasms / surgery
-
Melanoma / diagnostic imaging
-
Melanoma / drug therapy
-
Melanoma / pathology
-
Melanoma / secondary*
-
Melanoma / surgery
-
Patient Selection
-
Pneumonectomy*
-
Prognosis
-
Radiography
-
Radiotherapy, Adjuvant
-
Remission Induction
-
Survival Rate